A rodent platform entirely dedicated to innovation in experimental psychopathology 

Site Map OptoPath

News

OptoPath as if you were there
Training in endomicroscopy in vivo-Use of the Cellvizio system
A new Lab Manager for OptoPath
Prefrontal neuronal assemblies temporally control fear behaviour
Individual Variations in the Mechanisms of Nicotine Seeking: A Key for Research on Nicotine Dependence
A publication in Nature Neuroscience by Cyril Herry's team
An innovative system : Morphing Context for Fear Conditioning without handling the animal
When experts in obesity meet experts in memory
Organisation of a workshop on in depth tissue imaging on small-animal within the "Imaging the Cell" 8th meeting
Use of Cellvizio technology to visualize cerebral vessels network in a new publication from Jean-Luc Morel
Neuronal Circuits for Fear Expression and Recovery: Recent Advances and Potential Therapeutic Strategies
CocAddict Consortium meeting in Bordeaux
OptoPath represented at the 12th "Colloque de la Société des Neurosciences" in Montpellier, France
OptoPath new building ready to move in!!!
Blood brain barrier precludes the cerebral arteries to intravenously-injected antisense oligonucleotide
Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice
OptoPath represented at the 9th FENS Forum of Neuroscience
Two FRM (Fondation pour la Recherche Médicale) grants on Addiction awarded to OptoPath scientists
CB1 cannabinoid receptor determines metabolic responses to diet and leptin
COCADDICT: an ERA-NET Neuron-funded project
Deux chercheurs d'OptoPath dans le magazine "La Recherche"
The University of Bordeaux supports COCADDICT
A second publication for Optopath in Neuropsychopharmacology
First publication for OptoPath in Nature


TOP